
|Articles|September 6, 2013
VIDEO: Avoidable Costs in U.S. Healthcare
Doug Long, VP, Industry Relations, IMS Health, discusses the report: "Avoidable Costs in U.S. Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly."
Advertisement
Doug Long, VP, Industry Relations, IMS Health, discusses the report: "Avoidable Costs in U.S. Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly."
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
What the Newest Landmark PBM Reform Means for the Pharmacy Industry
4
Q&A: How Direct-to-Consumer Pharmacies Could Affect the Pharmacy Landscape
5























